🇺🇸 FDA
Patent

US 9579324

Therapeutically active compounds and their methods of use

granted A61KA61K31/506A61K31/53

Quick answer

US patent 9579324 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/506, A61K31/53, A61K31/5377, A61K45/06